Administrative Title

Assistant Professor

Biography

Dr. Madden is a faculty member in the Department of Family Medicine and Public Health Sciences. She is a sociologist and community-engaged substance use researcher who works with service providers, patients, and community organizations in collaborative interdisciplinary research teams. Her research program focuses on substance use among marginalized populations (e.g., people of color, low-income, and rural populations), assessing and preventing adverse outcomes related to substance use, and social dynamics affecting healthcare for people who use drugs. She specializes in primary data collection using qualitative methods, as well as mixed methods research design.

Please see Dr. Madden's CV. 

Education Training

PhD, University of Wisconsin-Madison (sociology)
MS, University of Wisconsin-Madison (sociology)
MPH, University of New Mexico
BA, Oberlin College (economics)

Interests

multidisciplinary research, stigma interventions, mixed methods research

Area of Expertise

Stigma, substance use, health services, qualitative research, community-engaged research, primary care

Research

 Current projects:

Title: Developing and Evaluating the Concerned Caregivers Education for Resource Navigation (ConCERN) Intervention for
Preventing Overdose
R01CE003668
Role: Co-Principal Investigator
Pooja Lagisetty (Principal Investigator)
The goal of this R01 is to develop and test a brief mobile intervention for the friends/family of people who use drugs that will improve the quality and effectiveness of their social support, and ultimately promote engagement with evidence-based treatment and harm reduction and reduce overdose risk.
Sponsor Name: CDC
09/2024 - 09/2029
Total Award: $ 3,750,000

Title: Leveraging CDC Opioid Overdose Surveillance Funding from the Albuquerque Area Southwest Tribal Epidemiology
Center to Create Tribal Data
R61DA049382
R33DA049382
Role: Co-Principal Investigator
Fares Qeadan (Co-Principal Investigator), Kamilla Venner (Co-Principal Investigator), Kevin English (Co-Investigator)
This two-phase project leverages CDC opioid overdose surveillance funding from the CDC to the Albuquerque Area Southwest Tribal Epidemiology Center to correct racial misclassification and create tribe-specific overdose data.
Sponsor Name: NIH-NIDA
09/2019 - 08/2024
Total Award: $ 1,272,568

Title: Planning a Multi-Level Intervention to Reduce Substance Use Stigma in HIV Prevention and Care
R34DA053758
Role: Co-Principal Investigator
Mark Greenwald (Co-Principal Investigator), Jonathan Cohn (Co-Investigator), Fares Qeadan (Co-Investigator)
The goal of this project is to undertake a community-engaged planning process for a trial testing stigma reduction interventions with primary care facilities. The results of the trial planning research provide scientific evidence demonstrating how healthcare organizations can address substance use stigma toward people who use drugs, and provided pilot data for an R01 submission.
Sponsor Name: NIH-NIDA
09/30/2021 - 07/31/2025
Total Award: $ 684,027

Title: Weighting Longitudinal Data to Assess Opioid Analgesia Tapering Outcomes among Patients with Co-occurring Chronic
Pain and Substance Use Disorder
R01DA057658
Role: Co-Investigator
Fares Qeadan (Principal Investigator), Philip Kroth (Co-Investigator), Pooja Lagisetty (Co-Investigator)
This project weights a large electronic medical records database and uses these data to estimate the effects of opioid tapering among patients with co-occurring chronic pain and substance use disorders.
Sponsor Name: NIH-NIDA
09/2022 - 07/2027
Total Award: $ 2,093,521

Title: Opioid Use Disorder Pharmaceutical Treatments: Investigating a Model and Measure of Intervention Stigma toward
Medication (OPTIMISM)
R15DA059765
Role: Co-Investigator
Rachel Winograd (Principal Investigator)
The goal of this R15 is to develop a standardized measure of "intervention stigma" toward medications for opioid use disorder, which means prejudice and discrimination towards the use or provision of medications to treat opioid addiction.
Sponsor Name: NIH-NIDA
09/2024 - 08/2029
Total Award: $ 421,499

Publications

Madden, EF, Frabis, F, Cohn, J, Qeadan, F, Mann, CR, Greenwald, MK. Perceptions of structural and provider-based substance use stigma interventions among primary care professionals. Drug and alcohol dependence reports. 2024;12:100259. PubMed PMID: PMC11301395. https://doi.org/10.1016/j.dadr.2024.100259 

Madden, EF, Barker, KK, Guerra, J, Villanueva, C, Sulzer, SH. Variation in intervention stigma among medications for opioid use disorder. SSM - Qualitative Research in Health. 2022;2:100161. doi: https://doi.org/10.1016/j.ssmqr.2022.100161.

Qeadan, F, Madden, EF . Associations between naloxone prescribing and opioid overdose among patients with acute and chronic pain conditions. Addiction. 2022;117(2):457-471. doi: https://doi.org/10.1111/add.15643.

Madden, EF, Christian, BT*, Lagisetty, PA, Ray, BR, Sulzer, SH. Treatment Provider Perceptions of Take-Home Methadone Regulation Before and During COVID-19. Drug and Alcohol Dependence. 2021;228:109100. doi: https://doi.org/10.1016/j.drugalcdep.2021.109100.

Madden, EF, Qeadan, F. Racial inequities in US naloxone prescriptions. Substance Abuse. 2020;41(2):232- 244. doi: https://doi.org/10.1080/08897077.2019.1686721.

Madden, EF. Intervention stigma: How medication-assisted treatment marginalizes patients and providers. Social Science & Medicine. 2019;232:324-331. PubMed PMID: 31125801. doi: https://doi.org/10.1016/j.socscimed.2019.05.027.

← Return to listing